Moderna vaccines produced in Spain that were blocked in Japan after impurities were found in the vials contained “steel particles,” the pharmaceutical company announced today, adding that the anomaly does not represent a health risk.
These are the conclusions of the research and laboratory analyzes conducted by the American pharmaceutical company and its distributor in Japan, Takeda, as a result of the Japanese government’s decision to block 1.63 million doses of the vaccine after foreign substances were detected in some jars.
The remains are believed to come from “an apparatus in the production chain” and “do not pose an undue risk from a medical point of view,” according to a joint statement published Wednesday by Moderna and Takeda after the investigation in which it has also The Spanish pharmaceutical company Rovi participated, which produces and packages the vaccine for the Japanese market, among others.
– .
